https://www.marketscreener.com/quote/stock/ACTINIUM-PHARMACEUTICALS--16113719/news/Actinium-Pharmaceuticals-Announces-Positive-Phase-3-Trial-Results-NCI-CRADA-for-AML-Drug-Candidates-43607512/?utm_source=telegram&utm_medium=social&utm_campaign=share